Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Clinical trial NCT05110196 · COMPLETED
Trial details
- NCT number
- NCT05110196
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-03
- Primary completion
- 2025-08-04
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.